Janux Therapeutics (JANX) is down -49.4%, or -$16.78 to $17.21.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JANX:
- Optimistic Buy Rating for Janux Therapeutics Despite Challenges and Promising Market Potential
- Janux Therapeutics price target lowered to $150 from $200 at Cantor Fitzgerald
- Janux Therapeutics price target lowered to $38 from $46 at Stifel
- Why Is Janux Therapeutics Stock (JANX) Crashing today?
- Janux Therapeutics price target lowered to $49 from $58 at BofA